An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial.

James H McMahonJillian S Y LauJanine RoneyBenjamin A RogersJason TrubianoJoseph SasadeuszJames S MoltonBradley GardinerSue J LeeJennifer F HoyAllen ChengAnton Y Peleg

Published in: Trials (2020)

clinicaltrials.gov NCT04445467 First posted 24-Jun-2020 FULL PROTOCOL: The full protocol is attached as an additional file, accessible from the Trials website (Additional file 1). In the interest in expediting dissemination of this material, the familiar formatting has been eliminated; this Letter serves as a summary of the key elements of the full protocol.

Keyphrases

placebo controlled
randomized controlled trial
double blind
open label
clinical trial
study protocol
phase ii
phase iii
phase ii study